Table II.
Immune profile of patients with the presence of anti-TIF1-γ antibodies
| No. | Sex | Antinuclear antibodies | TIF1-γ | Mi-2 | Ku | PM100 | PM75 | Jo1 | SRP | PL7 | PL12 | EJ | OJ | MDA5 | Other |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | F | 1: 2560 | low positive | + + + | + | – | – | – | – | – | – | – | – | – | – |
| 2 | F | NP | + | – | – | – | – | – | – | – | – | – | – | – | – |
| 3 | M | NP | + + + | – | – | – | – | – | – | – | – | – | – | – | – |
| 4 | F | 1: 2560 | low positive | – | – | – | – | – | – | – | – | – | – | + | DFS70 |
| 5 | F | 1: 320 | low positive | – | – | – | – | – | – | – | – | – | – | – | – |
| 6 | F | 1: 2560 | + + + | – | – | – | – | – | – | – | – | – | – | – | Ro52 |
| 7 | M | 1280 | + | – | – | – | – | – | – | – | – | – | + | – | |
| 8 | M | 2560 | + + + | – | – | – | – | – | – | – | – | – | + + + | – | Ro52 |
| 9 | F | 1280 | + | – | – | – | – | – | – | – | – | – | – | – | – |
| 10 | F | 2560 | ++ | – | – | – | – | – | – | – | – | – | – | – | – |
| 11 | F | negative | + + + | – | – | – | – | – | – | – | – | – | – | – | – |
NP – not performed; Mi-2 – anti-helicase protein antibodies; PM100 – anti-human exosome complex PM100; PM75 – anti-human exosome complex PM75; SRP – anti-signal recognition particle antibodies; PL7 – anti-threonyl tRNA; Pl12 – anti-alanyl tRNA; EJ – anti-glycyl tRNA; OJ – anti-isoleucyl tRNA; MDA5 – melanoma; differentiation-associated gene 5 antibodies; DFS70 – autoantibodies to dense fine speckles; Anti-Jo1 – anti-histidyl tRNA